Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Zeuzem, S.; Soriano, V.; Asselah, T. et al.

AN ANALYSIS OF RESPONSE RATES BY FIBROSIS STAGE IN PATIENTS TREATED WITH FALDAPREVIR, BI 207127 AND RIBAVIRIN IN THE SOUND-C2 STUDY

JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S498-S498


Zeuzem, S.; Soriano, V.; Asselah, T. et al.

An analysis of response rates by fibrosis stage in patients treated with faldaprevir, BI 207127 and ribavirin in the sound-C2 study

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. Bd. 28. 2013 S. 157-157


Asselah, Tarik; Zeuzem, Stefan; Soriano, Vicente et al.

An Analysis of Response Rates by Fibrosis Stage in Patients Treated With Faldaprevir, Bi 207127 and Ribavirin in the Sound-C2 Study

GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S976-S977


Gockel, Ines; Becker, Jessica; Wouters, Mira M. et al.

An Insertion of Eight Amino Acids in HLA-DQA1 and Three Amino Acid Substitutions in HLA-DQA1 and HLA-DQB1 Confer Risk to Idiopathic Achalasia

GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S142-S142


Schneider, V; Bullinger, L.; Zhang, L. et al.

Analysis of leukemic stem cell population comparing NPM1wt and NPM1mut AML patients and potential therapeutic targets

ONKOLOGIE. Bd. 36. 2013 S. 208-208


Tzartos, John S.; Stergiou, Christos; Kilidireas, Konstantinos et al.

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders

PLOS ONE. Bd. 8. H. 9. 2013


Wranke, A.; Yurdaydin, C.; Heidrich, B. et al.

Anti-HDV-IgM as a marker of disease activity in hepatitis delta

INTERNIST. Bd. 54. 2013 S. 28-29


Wranke, A.; Yurdaydin, C.; Heidrich, B. et al.

ANTI-HDV-IgM AS A MARKER OF DISEASE ACTIVITY IN HEPATITIS DELTA

JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S178-S178


Wranke, Anika; Yurdaydin, Cihan; Heidrich, Benjamin et al.

Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-alpha based therapy in hepatitis delta

HEPATOLOGY. Bd. 58. 2013 S. 651A-651A